Are two doses of misoprostol after mifepristone for early abortion better than one?

被引:20
作者
Coyaji, K.
Krishna, U.
Ambardekar, S.
Bracken, H.
Raote, V.
Mandlekar, A.
Winikoff, B.
机构
[1] Gynuity Hlth Projects, New York, NY 10010 USA
[2] KEM Hosp, Dept Obstet & Gynaecol, Pune, Maharashtra, India
[3] Larsen & Toubro Hlth Ctr, Bombay, Maharashtra, India
关键词
India; medical abortion; mifepristone; misoprostol; EARLY MEDICAL ABORTION; EARLY-PREGNANCY TERMINATION; RANDOMIZED-TRIAL; VAGINAL MISOPROSTOL; UNITED-STATES; EFFICACY; ACCEPTABILITY; WOMEN; GESTATION; REGIMENS;
D O I
10.1111/j.1471-0528.2006.01208.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective The objective of this study was to determine if a repeat dose of misoprostol following mifepristone or a single dose of misoprostol increases the efficacy of medical termination of pregnancy. Design Randomised, placebo controlled trial. Setting K.E.M. Hospital, Pune, India, and the Health Centre, Larsen and Toubro Limited, Mumbai, India. Sample A total of 300 women seeking an abortion with amenorrhoea of 8 weeks or less. Methods Women were randomised to receive one or two doses of 400 microgram oral misoprostol at the clinic 48 hours after administration of 200 mg mifepristone. Main outcome measure Complete abortion without surgical intervention. Results The repeat administration of misoprostol 400 microgram improved the complete abortion rate from 86 to 92% and significantly reduced the rate of continuing pregnancy from 7 to 1%. Almost all the women who were administered the additional dose of misoprostol were either very satisfied (58%) or satisfied (37%) with the method. Conclusion While an additional oral dose of 400 microgram misoprostol did not significantly increase the rate of complete abortion without surgical intervention, the additional dose did significantly reduce the rate of continuing pregnancies without compromising the acceptability and ease of use of the method.
引用
收藏
页码:271 / 278
页数:8
相关论文
共 50 条
  • [31] Mifepristone and misoprostol for early medical abortion: 18 months experience in the United States
    Hausknecht, R
    CONTRACEPTION, 2003, 67 (06) : 463 - 465
  • [32] Randomized trial of oral versus sublingual misoprostol 24 h after mifepristone for medical abortion
    Dahiya, Krishna
    Mann, Sonika
    Nanda, Smiti
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2011, 284 (01) : 59 - 63
  • [33] Vaginal misoprostol administered at home after mifepristone (RU486) for abortion
    Schaff, EA
    Stadalius, LS
    Eisinger, SH
    Franks, P
    JOURNAL OF FAMILY PRACTICE, 1997, 44 (04) : 353 - 360
  • [34] Comparison of misoprostol-only and combined mifepristone-misoprostol regimens for home-based early medical abortion in Tunisia and Vietnam
    Blum, Jennifer
    Raghavan, Sheila
    Dabash, Rasha
    Nguyen Thi Nhu Ngoc
    Chelli, Hela
    Hajri, Selma
    Conkling, Kathryn
    Winikoff, Beverly
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2012, 118 (02) : 166 - 171
  • [35] Effectiveness of early medical abortion using low-dose mifepristone and buccal misoprostol in women with no defined intrauterine gestational sac
    Goldstone, Philip
    Michelson, Jill
    Williamson, Eve
    CONTRACEPTION, 2013, 87 (06) : 855 - 858
  • [36] Comparison of 400 mcg buccal and 400 mcg sublingual misoprostol after mifepristone medical abortion through 63 days' LMP a randomized controlled trial
    Raghavan, Sheila
    Comendant, Rodica
    Digol, Irena
    Ungureanu, Sergiu
    Dondiuc, Iurie
    Turcanu, Steliana
    Winikoff, Beverly
    CONTRACEPTION, 2010, 82 (06) : 513 - 519
  • [37] Sequential use of mifepristone and misoprostol in treatment of early pregnancy failure appears more effective than misoprostol alone: a retrospective study
    van den Berg, Joyce
    van den Bent, Johan M.
    Snijders, Marcus P.
    de Heus, Roel
    Coppus, Sjors F.
    Vandenbussche, Frank P.
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2014, 183 : 16 - 19
  • [38] A STUDY OF DIFFERENT DOSES OF SUBLINGUAL MISOPROSTOL AFTER ORAL MIFEPRISTONE IN MEDICAL TERMINATION OF PREGNANCY
    Prabhu, Sujatha
    Krishnaswamy, Priyanka H.
    Shetty, Achal
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2015, 4 (91): : 15673 - 15678
  • [39] Acceptability and feasibility of the use of 400 μg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: Evidence from Uzbekistan
    Raghavan, Sheila
    Tsereteli, Tamar
    Kamilov, Asamidin
    Kurbanbekova, Dilfuza
    Yusupov, Dilmurod
    Kasimova, Feruza
    Jymagylova, Dilbar
    Winikoff, Beverly
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2013, 18 (02) : 104 - 111
  • [40] Efficacy and safety of mifepristone-buccal misoprostol for early medical abortion in an Australian clinical setting
    Goldstone, Philip
    Walker, Clara
    Hawtin, Katherine
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2017, 57 (03) : 366 - 371